All these PI3K isoforms promote tumor cell survival, proliferation and metastasis by regulating different processes including tumor cell metabolism, angiogenesis and by modulating the TME and immunity, mainly via the activation of the AKT/mTOR and the GSK3β/beta-catenin pathways (11) (Figure 1). The gene discussed is MTOR; the disease is neoplasm.